Home/Filings/4/0001209191-20-037075
4//SEC Filing

WAN MARK A 4

Accession 0001209191-20-037075

CIK 0001427925other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 7:12 PM ET

Size

7.4 KB

Accession

0001209191-20-037075

Insider Transaction Report

Form 4
Period: 2020-06-16
WAN MARK A
Director
Transactions
  • Award

    Common Stock

    2020-06-16+7,50011,250 total
  • Award

    Stock Option (Right to Buy)

    2020-06-16+15,00015,000 total
    Exercise: $1.43From: 2021-06-16Exp: 2030-06-15Common Stock (15,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
  • [F3]100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.

Issuer

ACELRX PHARMACEUTICALS INC

CIK 0001427925

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001190472

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:12 PM ET
Size
7.4 KB